Pertuzumab full pdf
page 2 of 35 full prescribing information: contents warning: left ventricular dysfunction and embryo-fetal toxicity 1 indications and usage. Pertuzumab DRUG NAME: Pertuzumab SYNONYM(S): COMMON TRADE NAME(S): PERJETA CLASSIFICATION: monoclonal antibody Special pediatric considerations are noted. The anti–human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere):. Background. Adding pertuzumab to trastuzumab and chemotherapy improves survival in HER2-positive early breast cancer and metastatic breast cancer. The CLEOPATRA (Clinical Evaluation of Trastuzumab and Pertuzumab) study demonstrated superior progression-free survival (PFS) and overall survival when pertuzumab. Academia.edu is a platform for academics to share research papers. The Oncologist is a journal devoted to medical and practice issues for surgical, radiation, and medical oncologists. Elotuzumab (brand name Empliciti, (Bristol-Myers Squibb and AbbVie), previously known as HuLuc63) is a humanized monoclonal antibody used in relapsed multiple myeloma. Protocols for the analytical characterization of therapeutic monoclonal antibodies. I – Non-denaturing chromatographic techniques. Worldwide, breast cancer is the most frequently diagnosed life-threatening cancer in women. In less-developed countries, it is the leading cause of cancer death. Surgery is the only curative modality for localized colon cancer (stage I-III). Surgical resection potentially provides the only curative option for patients. There are a number of guidelines on the prevention and treatment of nausea and vomiting in cancer patients. However, there is no clear consensus between these. Current Proposition 65 List. The current Proposition 65 list is available on-line below, as a pdf or Excel download or through WestLaw. The Excel document. Number: 0352. Policy. Aetna considers any of the following serum tumor markers for the stated indication medically necessary: Prostate-specific antigen (PSA).
Links to Important Stuff
Links
- HIGHLIGHTS OF PRESCRIBING INFORMATION.
- Medical Policies and Clinical Utilization Management.
- Clinical Review by Code List - Visitor.